Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1988-9-21
|
pubmed:abstractText |
Correlated analysis of the H-ras oncogenes product (p21) and of nuclear DNA content was performed by flow cytometry (FCM) in patients with DNA-aneuploid multiple myeloma (MM). Bone marrow cells from normal donors and MM patients in remission served as controls. Seventy-four percent of 23 patients with active MM had higher p21 fluorescence in aneuploid tumor cells than were observed in normal donor or myeloma remission bone marrows; 39% of the 23 patients also showed high H-ras p21 expression in diploid cells. There was an inverse relationship between p21 levels and the presence of trisomy 11; especially high p21 levels were noted in patient without trisomy 11. The frequent elevation of p21 protein in aneuploid plasma cells suggests the involvement of the H-ras oncogene in the pathophysiology of MM, which is further supported by a shorter survival among patients with high p21 levels.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
796-800
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3042048-Antibody Specificity,
pubmed-meshheading:3042048-Cell Nucleus,
pubmed-meshheading:3042048-Chromosomes, Human, Pair 11,
pubmed-meshheading:3042048-DNA, Neoplasm,
pubmed-meshheading:3042048-Flow Cytometry,
pubmed-meshheading:3042048-Humans,
pubmed-meshheading:3042048-Multiple Myeloma,
pubmed-meshheading:3042048-Proto-Oncogene Proteins,
pubmed-meshheading:3042048-Proto-Oncogene Proteins p21(ras)
|
pubmed:year |
1988
|
pubmed:articleTitle |
Correlated flow cytometric analysis of H-ras p21 and nuclear DNA in multiple myeloma.
|
pubmed:affiliation |
University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Department of Hematology, Houston 77030.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|